Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
142.98
-2.44 (-1.68%)
At close: Jul 2, 2024, 4:00 PM
142.96
-0.02 (-0.01%)
After-hours: Jul 2, 2024, 7:58 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novo Nordisk stock have an average target of 140.5, with a low estimate of 115 and a high estimate of 163. The average target predicts a decrease of -1.73% from the current stock price of 142.98.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Novo Nordisk stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
Buy | 3 | 3 | 4 | 4 | 4 | 4 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +11.90% | Jul 1, 2024 |
BMO Capital | BMO Capital | Buy Maintains $163 | Buy | Maintains | $163 | +14.00% | Jun 25, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +11.90% | Jun 20, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +11.90% | Jun 17, 2024 |
Argus Research | Argus Research | Strong Buy Maintains $125 → $160 | Strong Buy | Maintains | $125 → $160 | +11.90% | Jun 10, 2024 |
Financial Forecast
Revenue This Year
293.68B
from 232.26B
Increased by 26.45%
Revenue Next Year
354.82B
from 293.68B
Increased by 20.82%
EPS This Year
23.70
from 18.62
Increased by 27.30%
EPS Next Year
29.05
from 23.70
Increased by 22.56%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 317.8B | 418.1B | 494.2B | 568.8B | 672.0B |
Avg | 293.7B | 354.8B | 411.2B | 441.1B | 484.4B |
Low | 267.2B | 303.9B | 345.3B | 366.2B | 401.4B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 36.8% | 42.4% | 39.3% | 38.3% | 52.3% |
Avg | 26.4% | 20.8% | 15.9% | 7.3% | 9.8% |
Low | 15.1% | 3.5% | -2.7% | -10.9% | -9.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 26.25 | 34.32 | 42.95 | 46.44 | 51.61 |
Avg | 23.70 | 29.05 | 34.49 | 36.36 | 40.27 |
Low | 21.56 | 24.16 | 27.39 | 29.33 | 33.16 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 41.0% | 44.8% | 47.8% | 34.6% | 41.9% |
Avg | 27.3% | 22.6% | 18.7% | 5.4% | 10.8% |
Low | 15.8% | 1.9% | -5.7% | -15.0% | -8.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.